Etrumadenant

DB17506InvestigationalSmall molecule

Etrumadenant: Overview.

Mechanism: Pharmacologically active on Adenosine receptor A2b and Adenosine receptor A2a
Curator reviewed
Formula / weight: C₂₃H₂₂N₈O · 426.484 g/mol (avg)
Code names: AB-928

Resolves to

Compound

Structure

InChIKeyBUXIAWLTBSXYSW-UHFFFAOYSA-NSMILESCC1=C(C=CC=C1C#N)C1=NC(N)=NC(=C1)C1=CN(CC2=NC(=CC=C2)C(C)(C)O)N=N1

Targets

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

21Clinical trialsPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Etrumadenant, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.